AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ABACAVIR SULFATE AND LAMIVUDINE
8 registrations across 4 African markets— 6 active
Markets with ABACAVIR SULFATE AND LAMIVUDINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Abacavir and Lamivudine Dispersible Tablets 120… Dispersible Tablet | 🇰🇪Kenya | Micro Labs Limited | active | Oct 2030 |
| Abacavir Sulfate and Lamivudine Tablets 600/300mg Tablets | 🇷🇼Rwanda | Hetero Labs Limited | active | Aug 2029 |
| ABACAVIR_LAMIVUDINE 600/300MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ABACAVIR_LAMIVUDINE 60/30MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| Abacavir and Lamivudine Tablets USP 600 mg/300 mg Oral tablet | 🇹🇿Tanzania | Macleods Pharmaceuticals Limited | active | — |
| Abacavir (as sulfate) / Lamivudine Dispersible Tablets 120mg /60 mg Tablets | 🇹🇿Tanzania | Mylan Laboratories Limited | active | — |
| Abacavir (as Sulfate) and Lamivudine Dispersible Tablets 120/60 mg Dispersible Tablets | 🇹🇿Tanzania | Cipla Limited | active | — |
| Abacavir Sulfate 600mg and Lamivudine Tablets 300mg Film Coated Tablet | 🇹🇿Tanzania | Mylan Laboratories Limited | active | — |
ABACAVIR SULFATE AND LAMIVUDINE in Africa — Regulatory Overview
ABACAVIR SULFATE AND LAMIVUDINE is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Malawi, Kenya, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 6 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.